While recall campaigns are starting in certain countries (Israel, France, United States, etc.), Pfizer is working hard.
The American laboratory has started recruiting a dedicated sales force in the United States.
He also took the opportunity to expand his marketing team.
Pfizer intends to take advantage of the additional legitimacy offered last month by the FDA, the US health agency, which granted it final marketing authorization.
A sesame that Comirnaty, its vaccine, is currently the only one to have.
The laboratory hopes this will help them convince those who are reluctant to vaccinate.
Pfizer plans to communicate on television and social media, with promotion permitted in the United States.
Read also
Third dose of vaccine against Covid-19: should there be serological tests to check the level of antibodies?
Because the battle rages between the labs.
Not only to increase their market share in adult and adolescent vaccination, but also to secure their positions on third doses.
And for good reason: health agencies do not
This article is for subscribers only.
You have 69% left to discover.
To cultivate one's freedom is to cultivate one's curiosity.
Continue reading your article for € 1 the first month
I ENJOY IT
Already subscribed?
Log in